Gastroparesis following bone marrow transplantation
- 1 July 2001
- journal article
- Published by Springer Science and Business Media LLC in Bone Marrow Transplantation
- Vol. 28 (1), 59-62
- https://doi.org/10.1038/sj.bmt.1703084
Abstract
Patients often develop nausea, vomiting and bloating after bone marrow transplantation (BMT). These symptoms may interfere with nutrition and the ability to take oral medications. Gastroparesis is a recognized cause of these symptoms in non-transplant patients but less is known about patients who undergo BMT. Between January 1996 and March 1997, a total of 151 patients underwent BMT. Eighteen patients (12%) developed persistent symptoms suggestive of gastroparesis (persistent nausea, vomiting or bloating). Scintigraphic gastric emptying studies were performed to assess for gastroparesis. Prokinetic agents were administered at the time of study. The records on these patients were compared with those of all other patients undergoing BMT during the same time period without these symptoms. Nine patients who demonstrated delayed gastric emptying were further evaluated with esophagastroduodenoscopy and biopsy. Biopsy samples were reviewed for evidence of graft-versus-host disease (GVHD). Fourteen of 18 patients demonstrated delayed gastric emptying and most responded to prokinetic agents given at the time of study. Age, conditioning regimen, cytomegalovirus antigenemia and acute GVHD did not appear to be associated with the development of gastroparesis. Allogeneic BMT recipients were at higher risk than autologous BMT patients (26% vs 0%, P < 0.0001). of allogeneic bmt recipients, there was a nonsignificant trend of patients receiving tacrolimus to be less likely to experience gastroparesis than those receiving cyclosporine (27% vs 48%, P = 0.08). For the nine patients undergoing upper endoscopy, GVHD on gastric biopsy was an uncommon finding and was mild when present. Gastroparesis appears to be a common cause of nausea, vomiting and bloating following allogeneic BMT. This may occur less often with tacrolimus than cyclosporine because of the former agent's prokinetic properties. Patients usually respond to prokinetic drugs at the time of scintigraphy. GVHD and CMV infection do not appear to be major contributing factors.Keywords
This publication has 9 references indexed in Scilit:
- DIFFERENCES IN GASTRIC MOTOR ACTIVITY IN RENAL TRANSPLANT RECIPIENTS TREATED WITH FK-506 VERSUS CYCLOSPORINETransplantation, 1999
- Gastroparesis as a cause of nausea and vomiting after high-dose chemotherapy and haemopoietic stem-cell transplantationThe Lancet, 1998
- Prolonged nausea and vomiting after high dose chemotherapy and autologous peripheral stem cell transplantation in the treatment of high risk breast carcinomaCancer, 1997
- GASTRIC AND SMALL INTESTINAL MOTILITY IN HEALTH AND DISEASEGastroenterology Clinics of North America, 1996
- Gastroparesis After Lung TransplantationSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1995
- Upper gastrointestinal dysmotility in heart-lung transplant recipientsThe Annals of Thoracic Surgery, 1993
- Gastroparesis After a Presumed Viral Illness: Clinical and Laboratory Features and Natural HistoryMayo Clinic Proceedings, 1990
- Solid-phase gastric emptying in patients with Barrett's esophagusDigestive Diseases and Sciences, 1986
- A histopathologic study of gastric and small intestinal graft-versus-host disease following allogeneic bone marrow transplantationHuman Pathology, 1985